Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Aug 2026 for BeOne Medicines Ltd., €676k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Corazon D. Sanders: trading record in brief
Corazon D. Sanders discloses dealings in 2 companies, chiefly BeOne Medicines Ltd. and Ultragenyx Pharmaceutical Inc. Between 15 June 2026 and 25 August 2026, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 25 August 2026, reports a transaction of €676k in BeOne Medicines Ltd. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Corazon D. Sanders
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
2,075 shares@ US$380.00ADSSEC144:0001950047-26-008641
2,000 shares@ US$25.050.0015% mcap100.0% of flowCommonSEC144:0001950047-26-006073
945 shares@ US$265.49610.0006% mcap100.0% of flowADSSEC144:0001950047-26-006081
3 of 3 declarations
